金達威(002626.SZ)及子公司取得2項發明專利證書
格隆匯10月22日丨金達威(002626.SZ)公佈,公司、全資子公司廈門金達威維生素有限公司及廈門金達威生物科技有限公司近日收到國家知識產權局頒發的發明專利證書。
1.發明名稱:一種β-胡蘿蔔素的合成方法;該發明涉及一種β-胡蘿蔔素的合成方法,具體為將維生素A醇或其衍生物的有機膦鹽Ⅰ溶解於溶劑中,在鹼性化合物的催化下,在電流作用下發生氧化偶聯反應,得到β-胡蘿蔔素。本發明使用電氧化代替化學氧化試劑,氧化偶聯維生素A醇或其衍生物的有機膦鹽製備β-胡蘿蔔素,反應操作簡單,且副反應少,綠色環保,產物分離快速簡單,且純度高。
2.發明名稱:一種生物酶催化製備磷脂型DHA的方法;該發明提供一種生物酶催化製備磷脂型DHA的方法,所述方法包括將磷脂與含有DHA的物質經生物酶催化製得所述磷脂型DHA。本發明的方法不需要提前將DHA油脂解離為遊離的二十二碳六烯酸,工藝操作簡單安全,且反應副產物少,經過一次操作即可快速得到大量產物,從而簡化了操作工藝,減少了設備的投入。
上述專利的取得不會對公司生產經營產生重大影響,但有利於公司的技術創新,充分發揮自主知識產權優勢,進一步完善知識產權保護體系,增強公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.